MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

No Stability Information

Potassium iodide 65mg tablets (G.L. Pharma UK Ltd)

Explore other Potassium iodide formulations Explore other Potassium iodide 65mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Power Health Folic acid 400microgram tablets (Power Health Products Ltd)

Explore other Folic acid formulations Explore other Folic acid 400microgram tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Power Health Super Glucosamine 500mg & Chondroitin 400mg capsules (Power Health Products Ltd)

Explore other Glucosamine sulfate + Chondroitin formulations Explore other Glucosamine sulfate 500mg / Chondroitin sulfate 400mg capsules suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Power Health Vitamin E 200unit capsules (Power Health Products Ltd)

Explore other Alpha tocopherol formulations Explore other Vitamin E 200unit capsules suppliers

Stability Notes

There are no stability notes available for this medicine.

Incompatible

Pradaxa 110mg capsules (Boehringer Ingelheim Ltd)

Explore other Dabigatran etexilate formulations Explore other Dabigatran etexilate 110mg capsules suppliers

Stability Notes

Very sensitive to moisture so should be left in individual foil wrapping.

Provenance

This compatibility recommendation is derived from Pradaxa 110mg capsules (Boehringer Ingelheim Ltd).

Incompatible

Pradaxa 110mg capsules (CST Pharma Ltd)

Explore other Dabigatran etexilate formulations Explore other Dabigatran etexilate 110mg capsules suppliers

Stability Notes

Very sensitive to moisture so should be left in individual foil wrapping.

Provenance

This compatibility recommendation is derived from Pradaxa 110mg capsules (Boehringer Ingelheim Ltd).

Incompatible

Pradaxa 150mg capsules (Boehringer Ingelheim Ltd)

Explore other Dabigatran etexilate formulations Explore other Dabigatran etexilate 150mg capsules suppliers

Stability Notes

Very sensitive to moisture so should be left in individual foil wrapping.

Provenance

This compatibility recommendation is derived from Pradaxa 150mg capsules (Boehringer Ingelheim Ltd).

Incompatible

Pradaxa 150mg capsules (CST Pharma Ltd)

Explore other Dabigatran etexilate formulations Explore other Dabigatran etexilate 150mg capsules suppliers

Stability Notes

Very sensitive to moisture so should be left in individual foil wrapping.

Provenance

This compatibility recommendation is derived from Pradaxa 150mg capsules (Boehringer Ingelheim Ltd).

Incompatible

Pradaxa 75mg capsules (Boehringer Ingelheim Ltd)

Explore other Dabigatran etexilate formulations Explore other Dabigatran etexilate 75mg capsules suppliers

Stability Notes

Very sensitive to moisture so should be left in individual foil wrapping.

Provenance

This compatibility recommendation is derived from Pradaxa 75mg capsules (Boehringer Ingelheim Ltd).

Use with caution

Pramipexole 1.05mg modified-release tablets (A A H Pharmaceuticals Ltd)

Explore other Pramipexole formulations Explore other Pramipexole 1.05mg modified-release tablets suppliers

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 1.05mg modified-release tablets (Boehringer Ingelheim Ltd).

Use with caution

Pramipexole 1.05mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Pramipexole formulations Explore other Pramipexole 1.05mg modified-release tablets suppliers

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 1.05mg modified-release tablets (Boehringer Ingelheim Ltd).

Use with caution

Pramipexole 1.05mg modified-release tablets (Krka UK Ltd)

Explore other Pramipexole formulations Explore other Pramipexole 1.05mg modified-release tablets suppliers

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 1.05mg modified-release tablets (Boehringer Ingelheim Ltd).

Use with caution

Pramipexole 1.05mg modified-release tablets (Medihealth (Northern) Ltd)

Explore other Pramipexole formulations Explore other Pramipexole 1.05mg modified-release tablets suppliers

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 1.05mg modified-release tablets (Boehringer Ingelheim Ltd).

Use with caution

Pramipexole 1.05mg modified-release tablets (Teva UK Ltd)

Explore other Pramipexole formulations Explore other Pramipexole 1.05mg modified-release tablets suppliers

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 1.05mg modified-release tablets (Boehringer Ingelheim Ltd).

Use with caution

Pramipexole 1.05mg modified-release tablets (Viatris UK Healthcare Ltd)

Explore other Pramipexole formulations Explore other Pramipexole 1.05mg modified-release tablets suppliers

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 1.05mg modified-release tablets (Boehringer Ingelheim Ltd).

Print this list

Compatible

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.

Use with caution

Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.

Incompatible

Medicines under this category are not suitable for use inside MCAs.

No Stability Information

We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.